Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Host immune competence and local ischemia affects the functionality of engineered vasculature.

Host immune competence and local ischemia affects the functionality of engineered vasculature. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Host immune competence and local ischemia affects the functionality of engineered vasculature. Abstract Text:

    ruth r chenRuth R Chen,jonathan k snowJonathan K Snow,jack p palmerJack P Palmer,angela s linAngela S Lin,craig l duvallCraig L Duvall,robert e guldbergRobert E Guldberg,david j mooneyDavid J Mooney,

    OBJECTIVE: Localized and sustained delivery of vascular endothelial growth factor (VEGF) is a promising approach to overcome the limited efficacy of bolus delivery. The authors examined the effects of host immune competence and local ischemia on the functionality of new vessel networks formed with this approach. METHODS: Vessel structure and perfusion resulting from implantation of porous 85:15 poly(lactide-co-glycolide) scaffolds releasing VEGF165 were measured in both subcutaneous tissue and ischemic hindlimbs of immune competent C57BL/6 and immune deficient SCID mice. RESULTS: Sustained VEGF delivery resulted in a similar approximately 100% increase in vessel density within scaffolds in both implant sites, and both animal models. However, the resulting perfusion within scaffolds implanted in subcutaneous tissue increased modestly versus control (18-35%), while perfusion increased 52-110% above control when VEGF-releasing scaffolds were placed in ischemic hindlimbs of C57BL/6 or SCID mice. VEGF delivery improved perfusion in the entire ischemic limb (55 +/- 18% of the normal value by week 6; 138% increase over control) in SCID mice. Although C57BL/6 mice demonstrated spontaneous recovery from ischemia, VEGF delivery accelerated recovery as compared to control. CONCLUSIONS: Localized and sustained VEGF delivery can create functional vasculature that amplifies recovery of tissue ischemia. However, increases in local and regional perfusion were highly dependent on the implantation site and the animal model.

    Host immune competence and local ischemia affects the functionality of engineered vasculature. Publishing Authors By Initials

    rr chenRR Chen,jk snowJK Snow,jp palmerJP Palmer,as linAS Lin,cl duvallCL Duvall,re guldbergRE Guldberg,dj mooneyDJ Mooney,

    For similar peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors: vascular endothelial growth factor a research abstracts see: peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors: vascular endothelial growth factor a research

    PUBMED ID PMID:

    MEDLINE DATE:

    Host immune competence and local ischemia affects the functionality of engineered vasculature. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Microcirculation (New York, N.Y. : 1994)

    VOLUME: 14

    Page Numbers: 77-88

    Journal Abbreviation:

    ISSN: 1073-9688

    DAY: 3

    MONTH: Feb

    YEAR: 2007

    Host immune competence and local ischemia affects the functionality of engineered vasculature. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9434935

    Host immune competence and local ischemia affects the functionality of engineered vasculature. Keywords Mesh Terms:

    KEYWORDS: Vascular Endothelial Growth Factor A

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Host immune competence and local ischemia affects the functionality of engineered vasculature. Information

    Substance Name: Polyglactin 910

    Registry Number: 34346-01-5

    Grant and Affiliation Information for Host immune competence and local ischemia affects the functionality of engineered vasculature.

    AFFILIATION: Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: R01 HL069957

    ACRONYM: HL

    MEDLINETA: Microcirculation

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Host immune competence and local ischemia affects the functionality of engineered vasculature Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News